Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frangolias, D. D.
Right arrow Articles by Wilcox, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frangolias, D. D.
Right arrow Articles by Wilcox, P. G.
(Chest. 2001;119:434-441.)
© 2001 American College of Chest Physicians

Predictability of Oxygen Desaturation During Sleep in Patients With Cystic Fibrosis*

Clinical, Spirometric, and Exercise Parameters

Despina D. Frangolias, MPE, MPG, MSc and Pearce G. Wilcox, MD

* From the Pulmonary Research Laboratory, University of British Columbia, Vancouver, BC, Canada.

Correspondence to: Pearce G. Wilcox, MD, Department of Medicine, Pulmonary Research Laboratory, McDonald Research Wing, Room 292, 1081 Burrard St, St. Paul’s Hospital, Vancouver, British Columbia, V6Z 1Y6, Canada.

Background: The purpose of this study was to determine how common sleep-related desaturation with preserved awake resting pulse oximetric saturation (SpO2) was in a large cohort of adult cystic fibrosis (CF) patients with variable degrees of pulmonary disease. We then determined whether nocturnal desaturation could reliably be predicted from standard clinical and exercise parameters.

Methods: Seventy CF patients participated in the study (mean [SD] age, 27.3 [8.7] years; women, 54%; percent predicted FEV1 [%predFEV1], 55.7% [23.9%]). Nocturnal, resting, and exercise SpO2 were measured. Nocturnal oximetry was measured in the patient’s home. Maximal oxygen capacity (O2max) was determined from a graded exercise test on a stationary bicycle ergometer. The Shwachman-Kulczycki (S-K) illness severity score was calculated incorporating categories of functional capacity, physical examination, nutrition, and chest radiograph.

Results: Multivariate analysis reported significant differences (p < 0.0001) between pulmonary disease severity and overall distribution of nocturnal SpO2, with the main difference being for patients with severe pulmonary disease (%predFEV1 of < 50%) compared to patients with mild or moderate disease in the SpO2 intervals of 100 to 96% (p < 0.0001) and 90 to 86% (p = 0.0001). Pulmonary function, S-K clinical scores, O2max, and resting and maximal SpO2 correlated significantly (p < 0.05) with nocturnal SpO2 levels. Stepwise discriminant analysis identified %predFEV1 (or S-K scores) and resting SpO2 as the parameters that could best discriminate patients not likely to experience nocturnal desaturation. Specifically, our equation could predict 91% of cases less likely to nocturnally desaturate, but could only modestly predict those more likely to desaturate (ie, 26% of cases).

Conclusions: Spirometric parameters and measurements of awake resting oxygenation are of limited utility in predicting nocturnal desaturation. Nocturnal oximetry should be considered in patients with moderate to severe lung disease even with preserved awake resting SpO2.

Key Words: cystic fibrosis • exercise desaturation • nocturnal hypoxemia




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
D S Urquhart, H Montgomery, and A Jaffe
Assessment of hypoxia in children with cystic fibrosis
Arch. Dis. Child., November 1, 2005; 90(11): 1138 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. D. Frangolias, J. Ruan, P. J. Wilcox, A. G. F. Davidson, L. T. K. Wong, Y. Berthiaume, R. Hennessey, A. Freitag, L. Pedder, M. Corey, et al.
{alpha}1-Antitrypsin Deficiency Alleles in Cystic Fibrosis Lung Disease
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 390 - 396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. D. Frangolias, C. L. Holloway, S. Vedal, and P. G. Wilcox
Role of Exercise and Lung Function in Predicting Work Status in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 150 - 157.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. A. Milross, A. J. Piper, M. Norman, G. N. Willson, R. R. Grunstein, C. E. Sullivan, and P. T. P. Bye
Predicting Sleep-Disordered Breathing in Patients With Cystic Fibrosis
Chest, October 1, 2001; 120(4): 1239 - 1245.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.